Patients’ Willingness and Perspectives Toward Chimeric Antigen Receptor T-Regulatory Cell Therapy for Inflammatory Bowel Diseases

BACKGROUND: Inflammatory bowel disease is a life-changing disease resulting from recurrent intestinal inflammation. Current therapies (eg, steroids and biologics) are associated with mild to severe side effects, and none provide a cure. Recent research has focused on genetically engineering gut-spec...

Descripción completa

Detalles Bibliográficos
Autores principales: Vent-Schmidt, Jens, Goldsmith, Laurie J, Steiner, Theodore S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Observations and Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802168/
https://www.ncbi.nlm.nih.gov/pubmed/36777762
http://dx.doi.org/10.1093/crocol/otaa085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9802168/
https://www.ncbi.nlm.nih.gov/pubmed/36777762
http://dx.doi.org/10.1093/crocol/otaa085

Ejemplares similares